MatchaDB

2023学術論文無料で読める

Editorial: Women in gastrointestinal cancers, volume II: 2022

Nadia Μ. Hamdy, Lisardo Boscá, Sukh Mahendra Singh, Srinivasa Reddy Bonam, Igor Kišš, Divya P. Kumar, Aditi Banerjee

Frontiers in Oncology

出版社で読む→無料の全文→PubMed

要旨

Women in Gastrointestinal Cancer Vol II: 2022 EDITORIAL This editorial presents the inaugural Frontiers in Oncology (FIO) 'Women in Gastrointestinal Cancer Vol II: 2022" series of article collections. The research topic collection highlights the diversity of research performed across the entire breadth of oncology research by women scientists pursuing STEM careers. Nine (9) research articles, from 14 submitted to FIO within this section, published under this research topic by 92 authors, aimed to present advances in theory, experiment, and methodology, with applications to compelling problems related to gastric cancers: gastrointestinal (GI) cancer: Hepato-Pancreatic Biliary (HPB) cancers. 1/9 is a brief research report article titled "the BET inhibitor JQ1 potentiates the anticlonogenic effect of radiation in pancreatic cancer cells". 1/9 is a case report article titled "a female with synchronous multiple primary malignant tumors in the esophagogastric junction, duodenum, and pancreas: Case report and review of the literature". Methodology Clinical trial article 1/9 under the title "implementing pharmacogenetic testing in gastrointestinal cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 screening to guide chemotherapy dosing". Four out of the nine (4/9) published articles are original research articles exploring the tumor-immune interactions in the tumor microenvironment (TME) and identifying new prognostic and/or therapeutic biomarkers to assist in novel decoding mechanism(s) of tumor immunotherapy as well as being confined with personalized treatment based on geno/pheno-typic evaluations. These four articles are, first "Evaluation of Galanin Expression in Colorectal Cancer (CRC): An Immunohistochemical (IHC)…

要旨は短縮されています。出典で要旨の全文を読む。

要旨の文章はPubMed、OpenAlex、Europe PMCから取得したもので、著者と出版社に帰属します。

研究の種類

システマティックレビュー・メタ解析

過去の研究を体系的に検索し、統合して分析したもの。

タイトル、要旨、件名から自動的に割り当てています。

トピック

ここでは抹茶が主題のひとつです(キーワードに記載)。

キーワードと件名

あなたのリサーチフォルダー

この研究を引用する

Nadia Μ. Hamdy, Lisardo Boscá, Sukh Mahendra Singh, Srinivasa Reddy Bonam, Igor Kišš, Divya P. Kumar, Aditi Banerjee. (2023). Editorial: Women in gastrointestinal cancers, volume II: 2022. Frontiers in Oncology. https://doi.org/10.3389/fonc.2023.1192814

DOI: 10.3389/fonc.2023.1192814 · PubMed ID: 37265801

代謝と体重についてさらに

2018学術論文

Effect of tea products on the in vitro enzymatic digestibility of starch.

Zhang H, Jiang Y, Pan Jほか — Food chemistry

The importance of postprandial hyperglycemia in the treatment of diabetes has been recognized recently. Tea products, such as tea polyphenols (TP), epigallocatechin gallate (EGCG), matcha, and instant tea, were chosen as constituents of…

試験管内・細胞研究代謝と体重抗酸化物質とポリフェノール腸とマイクロバイオーム被引用76回
2018学術論文無料で読める

Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways.

Bonuccelli G, Sotgia F, Lisanti MP — Aging

Matcha green tea (MGT) is a natural product that is currently used as a dietary supplement and may have significant anti-cancer properties. However, the molecular mechanism(s) underpinning its potential health benefits remain largely…

試験管内・細胞研究代謝と体重抗酸化物質とポリフェノールがん被引用75回
2020学術論文

Changes in Intestinal Microbiota of Type 2 Diabetes in Mice in Response to Dietary Supplementation With Instant Tea or Matcha.

Zhang HH, Liu J, Lv YJほか — Canadian journal of diabetes

Objective: Gut microbiota plays a key role in metabolism and health in diabetes patients with gastrointestinal microbiota dysbiosis. Thus, regulating the ecological balance of gut microbiota may provide a pathway toward improvement for…

動物研究代謝と体重腸とマイクロバイオーム市場・文化・持続可能性被引用74回

ライブラリ全体を見る→